EUVIMEDEUVIMED entdecken
Crossref

Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A

Xiaoxi Liu, Jia Lai, Xiaoqin Zhang, Anguo Wu iD, Ling Zhou, Yueyue Li, Qianqian Huang, Xinwu Huang, Hua Li, Cai Lan, Jian Liu, Feihong Huang und 1 weitere

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Xiaoxi Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Megakaryocytes, Thrombopoiesis, Cell Differentiation, Harmine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, The Open Project Program of State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MegakaryocytesThrombopoiesisCell DifferentiationHarminerac1 GTP-Binding ProteinReceptor, Serotonin, 5-HT2AAnimalsMiceHumansThrombocytopeniaMAP Kinase Signaling SystemBlood PlateletsMaleMolecular Docking Simulation

Stichwörter der Autor:innen

5‐HTR2A/Rac1/Cdc42/JNKharminemegakaryocyte differentiationradiationthrombocytopeniathrombopoiesis

Substanzen

Harminerac1 GTP-Binding ProteinReceptor, Serotonin, 5-HT2A

Autor:innen und Institutionen

  • School of Pharmacy, Southwest Medical University, Luzhou, China.
  • School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
  • Education Ministry Key Laboratory of Medical Electrophysiology, Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation f…
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID-Profile: Anguo Wu, Jianming Wu

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • The Open Project Program of State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China
  • The Open Project Program Fund of Chengdu University of Traditional Chinese Medicine State Key Laboratory of Southwestern Chinese Medicine Resources
  • The Science and Technology Planning Project of Yibin City
  • The school-level Fund of Southwest Medical University

Zitieren

APA

Liu, X., Lai, J., Zhang, X., Wu, A., Zhou, L., Li, Y., Huang, Q., Huang, X., Li, H., Lan, C., Liu, J., Huang, F., & Wu, J. (2024). Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A. Phytotherapy Research. https://doi.org/10.1002/ptr.8317

Vancouver

Liu X, Lai J, Zhang X, Wu A, Zhou L, Li Y, et al. Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A. Phytotherapy Research. 2024. doi:10.1002/ptr.8317

BibTeX
@article{Liu2024,
  author = {Liu, Xiaoxi and Lai, Jia and Zhang, Xiaoqin and Wu, Anguo and Zhou, Ling and Li, Yueyue and Huang, Qianqian and Huang, Xinwu and Li, Hua and Lan, Cai and Liu, Jian and Huang, Feihong and Wu, Jianming},
  title = {Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8317}
}
Kostenlos starten →